Results 141 to 150 of about 22,744 (213)

Prediction of Resectability of Peritoneal Disease in Ovarian Cancer Patients Using the Peritoneal Cancer Index (PCI) and Fagotti Score on MRI. [PDF]

Cancers (Basel)
Konidari M, Gourtsoyianni S, Thomakos N, Lymperopoulou G, Tzavara C, Pergialiotis V, Rodolakis A, Moulopoulos LA, Bourgioti C.   +8 more
europepmc   +1 more source

Hyperthermic intraperitoneal chemotherapy in ovarian cancer: a comprehensive review. [PDF]

Front Oncol
Li Y, Xu X.
europepmc   +1 more source

Kidney transplantation with bone marrow augmentation: Five-year outcomes [PDF]

, 2001
A Jain, A Zeevi, A.S Rao, Barber, C.A Vivas, Ciancio, Ciancio, Corry, E.A Gray, Fontes, Garcia-Morales, I Dvorchik, J McCauley, J McMichael, J.J Fung, M Valenti, M.L Jordan, McDaniel, Miller, Monaco, Monaco, P Randhawa, Quesenberry, R Shapiro, R.J Corry, Rao, Shapiro, Shapiro, Shapiro, Shapiro, Spitzer, T.E Starzl, V.P Scantlebury   +32 more
core   +1 more source

Tertiary Cytoreduction for Recurrent Epithelial Ovarian Cancer: a Multicenter Study in Turkey [PDF]

, 2016
Macit Arvas, Yavuz Salihoğlu, Veysel Şal, Tetyana Hariyan, Hamdullah Sözen, İlker Kahramanoğlu, Samet Topuz, Fuat Demirkıran, Cem İyibozkurt, Tugan Beşe, Burçin Salman Özgü, Doğan Vatansever, Nedim Tokgözoğlu, Sinan Berkman, Hasan Turan, Ergin Bengisu, Nigar Sofiyeva, İrem Demiral, M. Mutlu Meydanli   +18 more
openalex   +1 more source

Splenectomy in Ovarian Cancer Cytoreductive Surgery: Pre-operative Prediction of Disease, Peri-operative Outcomes and Post-operative Adherence to Antimicrobial Prophylaxis and Immunisation. [PDF]

In Vivo
Corha A, Graham R, Chandrasekaran D, Macdonald ND, Dawas K, Kotsopoulos IC.   +5 more
europepmc   +1 more source

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS + HIPEC): an initial experience at a Tertiary care Hospital in Pakistan. [PDF]

Pak J Med Sci
Aimon S, Khan HM, Khan U, Atiq M.
europepmc   +1 more source

Impact of multimodal prehabilitation as part of ERAS on surgical outcomes in high-risk advanced ovarian cancer patients undergoing primary cytoreduction without HIPEC

V.V. Yevsieieva, V.I. Chernii, K.V. Kharchenko   +2 more
openalex   +2 more sources

The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer

, 2014
Erin K. Crane, Charlotte C. Sun, Pedro T. Ramírez, Kathleen M. Schmeler, Anaís Malpica, David M. Gershenson   +5 more
openalex   +1 more source

Robotic secondary cytoreduction in recurrent ovarian cancer: a tailored approach for kidney transplant recipients. [PDF]

Facts Views Vis Obgyn
Russo SA, Oliva R, Certelli C, Ammar S, Palmieri L, Lodoli C, Santullo F, Santoro A, Fagotti A, Scambia G, Gallotta V.   +10 more
europepmc   +1 more source

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [PDF]

, 2016
Cedric Demtröder, Clemens Tempfer, Jürgen Zieren, Marc A. Reymond, Nurettin Albayrak, Ramy Girshally   +5 more
core   +1 more source